Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway
European Journal of Pharmacology · 2023
DOI: 10.1016/j.ejphar.2023.176178 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2023. Verfasst von H H Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: 2335478814@qq.com. Hauptthemen laut MEDLINE: NF-kappa B, HMGB1 Protein. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Mobilisation
Abstract (Originalsprache)
Oxidative stress and inflammation have been implicated in hepatic fibrosis. Antioxidant and anti-inflammatory activities are among the pharmacological effects of hyperoside. This study aimed to evaluate the impact of hyperoside on hepatic fibrosis and elucidate the underlying processes that perpetuate this relationship. The findings indicated that hyperoside significantly protects mouse livers against damage, inflammation, and fibrosis. Specifically, attenuation of hepatic fibrosis is associated with lower expression of HMGB1 protein and reduced expression of Toll-like receptor 4, PARP-1, and nuclear factor-kB (NF-κB) p65 mRNA and protein. Furthermore, hyperoside inhibited the cytoplasmic translocation of HMGB1 and nuclear localization of NF-κB p65 in the hepatic tissues of mice. The results of this study indicate that hyperoside may impose a blocking or reversing effect on hepatic fibrosis; additionally, the corresponding hyperoside-dependent mechanism may be linked to PARP-1-HMGB1 pathway regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: 2335478814@qq.com.
- Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: 2695270917@qq.com.
- Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: 361814429@qq.com.
- Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: 737099102@qq.com.
- Health Science Center, Hubei Minzu University, Enshi, 445000, China. Electronic address: hdb66910@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zeng, H. H., Ma, M., Wang, Y. L., Chen, M. H., & Huang, D. B. (2023). Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2023.176178
Vancouver
Zeng HH, Ma M, Wang YL, Chen MH, Huang DB. Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway. European Journal of Pharmacology. 2023. doi:10.1016/j.ejphar.2023.176178
BibTeX
@article{Zeng2023,
author = {Zeng, H H and Ma, M and Wang, Y L and Chen, M H and Huang, D B},
title = {Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway},
journal = {European Journal of Pharmacology},
year = {2023},
doi = {10.1016/j.ejphar.2023.176178}
}
EUVIMED